Related Experiment Video
Updated: May 28, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Evaluation of 3',4'-Di-O-acetyl-cis-khellactone as a Putative Antagonist of PPARγ Using Experimental and
Elix Alberto Domínguez-Mendoza1, Fernando Daniel Prieto-Martínez2, Yelzyn Galván-Ciprés3
1Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana-X, Ciudad de México 04960, Mexico.
Abstract:
Obesity and Non-Alcoholic Fatty Liver Disease (NAFLD) are closely linked and constitute a growing public health concern. In this work, we evaluated the antiobesity effect of an enantiomerically enriched mixture of 3',4'-di-O-acetyl-cis-khellactone (DOAcK), a natural product derivative obtained by asymmetric synthesis. This molecule is a derivative of praeruptorin, a major component found in Arracacia tolucensis as well as many other species from the Apiaceae family. A comprehensive evaluation of DOAcK was conducted using both experimental and theoretical methods. DOAcK showed significant effects in animal models, with additional evidence of diminished expression of PPARγ. Finally, we conducted molecular modeling to elucidate the putative interaction between DOAcK and PPARγ, uncovering the significant role of the so-called Ω-loop, near the ligand binding domain. In summary, these positive findings of DOAcK demonstrate that the use of this natural product could be helpful in preventing NAFLD and obesity.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
